| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $0.08 (Beat by $0.04) |
| EPS GAAP Actual | $0.08 (Beat by $0.04) |
| Revenue Actual | $0.239708B |
| Revenue Surprise | Beat by $239.708M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.2329B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2028 | 0.35 | 23.43 | 0.34847 | 0.35149 | 1 |
| Jun 2028 | 0.55976 | 14.65 | 0.55604 | 0.56363 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.08 | 0.08 | 0.239708B | 12.81% | 7.68M |
| FQ3 2025 (Sep 2025) | 0.06 | 0.05 | 0.236105B | 13.11% | 22.21M |
| FQ2 2025 (Jun 2025) | -0.0058 | -0.0058 | 0.221417B | 9.94% | 221.42M |
| FQ1 2025 (Mar 2025) | -0.08 | -0.09 | 0.218142B | 11.49% | 12.14M |
| FQ4 2024 (Dec 2024) | -0.0976 | -0.100933 | 0.208999B | 9.62% | 1.33M |
| FQ3 2024 (Sep 2024) | -0.0363 | -0.0363 | 0.205142B | 11.04% | 205.14M |
| FQ2 2024 (Jun 2024) | -0.0125 | -0.0125 | 0.199401B | 11.3% | 199.4M |
| FQ1 2024 (Mar 2024) | -0.0433 | -0.0433 | 0.193071B | 10.63% | 193.07M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.2329B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ3 2026 (Jul 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.26B | -- | 0.26B | 0.26B | 1 |
| FQ4 2026 (Dec 2026) | 0.25B | 4.12 | 0.25B | 0.25B | 1 |
| FQ3 2026 (Jul 2026) | 0.24B | 0.6 | 0.24B | 0.24B | 1 |
| FQ1 2026 (Mar 2026) | 0.23B | 6.34 | 0.23B | 0.23B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0 | 0.08 | 0.08 | 100% |
| FQ3 2025 (Sep 2025) | 0.01 | 0.06 | 0.05 | 83.33% |
| FQ2 2025 (Jun 2025) | -0.0058 | -0.0058 | 100% | |
| FQ1 2025 (Mar 2025) | 0.01 | -0.08 | -0.09 | 112.5% |
| FQ4 2024 (Dec 2024) | 0.003333 | -0.0976 | -0.100933 | 103.41% |
| FQ3 2024 (Sep 2024) | -0.0363 | -0.0363 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0125 | -0.0125 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0433 | -0.0433 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.23B | $0.24B | $7.68M | 3.2% |
| FQ3 2025 (Sep 2025) | $0.21B | $0.24B | $22.21M | 9.4% |
| FQ2 2025 (Jun 2025) | $0B | $0.22B | $221.42M | 100% |
| FQ1 2025 (Mar 2025) | $0.21B | $0.22B | $12.14M | 5.57% |
| FQ4 2024 (Dec 2024) | $0.21B | $0.21B | $1.33M | 0.64% |
| FQ3 2024 (Sep 2024) | $0B | $0.21B | $205.14M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.2B | $199.4M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.19B | $193.07M | 100% |